We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Alliance Against Chronic Respiratory Diseases

By HospiMedica staff writers
Posted on 19 Apr 2006
A voluntary global alliance of 41 national and international organizations has been launched to focus on reducing the global disease burden of chronic respiratory diseases.

The Global Alliance Against Chronic Respiratory Diseases (GARD, Geneva, Switzerland), launched in March 2006 in Beijing (China), aims to achieve these goals by integrating and strengthening surveillance, prevention, and treatment efforts. More...
The key objectives for GARD involve a comprehensive approach to fight chronic respiratory diseases, and in many cases this will build on existing initiatives. These include developing a standard way of obtaining data on risk factors and disease; defining strategies to establish GARD as a public health priority; encouraging countries to implement health promotion and chronic disease policies (such as tobacco control); and making recommendations on how to provide simple and affordable strategies for the management of chronic respiratory diseases for all patients in all countries.

''The goal of GARD,'' said Professor Jean Bousquet, an expert on respiratory diseases at the Hospital Arnaud De Villeneuve (Montpellier, France), and GARD chairman, ''is to reduce the global burden of chronic respiratory diseases. As the prevalence and global burden of chronic respiratory diseases are expected to increase considerably in the near future, it is clear that immediate action is greatly needed and the cost for inaction is unacceptable.''

Currently, hundreds of millions of people suffer from chronic respiratory diseases, including 300 million people with asthma, 80 million people with moderate to severe chronic obstructive pulmonary disease (COPD), and millions of others with mild COPD, allergic rhinitis, and other chronic respiratory diseases, which are often undiagnosed. The World Health Organization (WHO, Geneva, Switzerland) estimates that some four million people died of chronic respiratory diseases in 2005 and that total deaths will increase by 30% in the next 10 years, if action is not taken now.



Related Links:
Global Alliance Against Chronic Respiratory Diseases

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Electrode Solution and Skin Prep
Signaspray
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.